Updates

Stay informed on recent developments in the world of biomarkers for bladder cancer surveillance

Webinar on Bladder EpiCheck®, for NMIBC monitoring

Webinar on Bladder EpiCheck®, for NMIBC monitoring

On Tuesday October 6th  2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”. Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands,...

read more
Interested in the place of urinary markers in NMIBC follow-up?

Interested in the place of urinary markers in NMIBC follow-up?

Watch a webinar by Prof. Fred Witjes On Thursday 24 September 2020, Nucleix, Israel and Oncotest-Rhenium, Israel organised the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes,...

read more
Methylation-based assay & TPS reporting of urine cytology

Methylation-based assay & TPS reporting of urine cytology

Reviewed by Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, the Netherlands)   Data from a recent study support the use of a urinary methylation-based assay, i.e. Bladder EpiCheck®, to accurately identify recurrence in patients with high-grade...

read more
Invitation to webinar on NMIBC follow-up

Invitation to webinar on NMIBC follow-up

Nucleix, Israel and Oncotest-Rhenium, Israel are pleased to invite you to the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”, led by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands. The webinar...

read more
BCaMonitor.org is now live!

BCaMonitor.org is now live!

We are excited to announce that our web platform is now available. We aim to share information on bladder cancer biomarker tests, how they can provide accurate detection of recurrence and decrease patient burden. Check out our: informative slide resource on biomarker...

read more

Stay informed about new releases in the field